PD Dr. Michael Erdmann



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Brief Communication: Treatment Outcomes for Advanced Melanoma of Unknown Primary Compared With Melanoma With Known Primary (2024) Persa OD, Cecile Hassel J, Steeb T, Erdmann M, Karimi B, Stege H, Klespe KC, et al. Journal article Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events (2024) Koch E, Petzold A, Dippel E, Erdmann M, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma. (2024) Albrecht LJ, Dimitriou F, Grover P, Hassel JC, Erdmann M, Forschner A, Johnson DB, et al. Journal article Patients’ and dermatologists’ preferences in artificial intelligence–driven skin cancer diagnostics: A prospective multicentric survey study (2024) Haggenmüller S, Maron RC, Hekler A, Krieghoff-Henning E, Utikal JS, Gaiser M, Müller V, et al. Journal article Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics (2024) Haggenmüller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, Utikal JS, et al. Journal article Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning (2024) Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, et al. Journal article Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center Analysis (2023) Glaser N, Petzold A, Wessely A, Kaufmann M, Koch E, Knorr H, Voskens C, et al. Journal article Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study (2023) Lodde GC, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study (2023) Kirchberger M, Gfesser M, Erdmann M, Schliep S, Berking C, Heppt M Journal article S1-Leitlinie dermales und subkutanes Leiomyosarkom (2023) Helbig D, Dippel E, Erdmann M, Frisman A, Kage P, Leiter U, Mentzel T, et al. Journal article
1 2 3 4 5